Search

Author/Creator Shenoy, Shalini

1. A single‐center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease. Issue 1 (10th October 2019)

Authors:
Bhatt, Sima T.; Schulz, Ginny; Hente, Monica; Slater, Ashley; Murray, Lisa; Shenoy, Shalini; Bednarski, Jeffrey J.
Journal:
Pediatric blood & cancer
Issue:
Volume 67:Issue 1(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Comment on: Acquired monosomy 7 myelodysplastic syndrome in a child with clinical features of dyskeratosis congenita and IMAGe association. Issue 1 (17th August 2017)

Authors:
Wilson, David B.; Bessler, Monica; Ferkol, Thomas W.; Shenoy, Shalini; Amano, Naoko; Ishii, Tomohiro; Shima, Hirohito; Narumi, Satoshi
Journal:
Pediatric blood & cancer
Issue:
Volume 65:Issue 1(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study. Issue 11 (November 2019)

Authors:
Eapen, Mary; Brazauskas, Ruta; Walters, Mark C; Bernaudin, Françoise; Bo-Subait, Khalid; Fitzhugh, Courtney D; Hankins, Jane S; Kanter, Julie; Meerpohl, Joerg J; Bolaños-Meade, Javier; Panepinto, Julie A; Rondelli, Damiano; Shenoy, Shalini; Williamson, Joi; Woolford, Teonna L; Gluckman, Eliane; W...
Journal:
Lancet
Issue:
Volume 6:Issue 11(2019)
Page Start:
e585
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗